Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Adenosine/adverse effects"'
Autor:
Johanne SILVAIN, Sotir Marchev, Frans Van de Werf, Juhani Airaksinen, Ru San Tan, Daniel Duerschmied, Bela Merkely, Rolf Wachter, Bassem A. Samad, Philippe Gabriel STEG, Dirk Westermann, Didier CARRIE, Fernando Lanas, MICHELE SENNI, José Ramón Rumoroso, Wanwarang Wongcharoen, Grzegorz Opolski, Niall Mahon, Sandro Brusich
Publikováno v:
Cannon, C P, Bhatt, D L, Oldgren, J, Lip, G Y H, Ellis, S G, Maeng, M, Merkely, B, Manassie, J, Januzzi, J L, Ten Berg, J M, Steg, P G, Hohnloser, S H & RE-DUAL PCI Steering Committee and Investigators 2017, ' Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation ', The New England Journal of Medicine, vol. 377, no. 16, pp. 1513-1524 . https://doi.org/10.1056/NEJMoa1708454
BACKGROUND: Triple antithrombotic therapy with warfarin plus two antiplatelet agents is the standard of care after percutaneous coronary intervention (PCI) for patients with atrial fibrillation, but this therapy is associated with a high risk of blee
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e13931000e1ba7b7512f50c0dfddb1d3
http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-145511
http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-145511
Publikováno v:
Revue médicale suisse, Vol. 6, No 240 (2010) pp. 547-554
Pulmonary fibrosis is an extraarticular manifestation of rheumatoid arthritis (RA), which appears between 20 to 40% of cases. MTX is an ordinary treatment used for patients with RA. It has been suggested in some studies that a link between the use of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1400::b28ff166e9cafe3a604763162df85530
https://archive-ouverte.unige.ch/unige:24251
https://archive-ouverte.unige.ch/unige:24251
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.